This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.

This report presents a first-of-its-kind collaborative tribal-federal blueprint for improving the behavioral health of American Indians and Alaska Natives. This was developed in response to calls from tribal leaders for improved collaboration with federal agencies to address the behavioral health of their communities.

This executive summary of the Surgeon General's Report on Alcohol, Drugs, and Health addresses alcohol, illicit drugs, and prescription drug misuse in the United States. Chapters of the report cover neurobiology, prevention, treatment, recovery, health systems integration, and recommendations for the future.

This Surgeon General's Report on Alcohol, Drugs, and Health addresses the prevalence of alcohol, illicit drugs, and prescription drug misuse in the United States. Chapters of the report cover neurobiology, prevention, treatment, recovery, health systems integration, and recommendations for the future.

This report provides policymakers with information about treatment service expenditures for mental illness and substance use disorders. It covers sources of financing and spending trends from 2010 to 2020.

This report provides national and state-level statistics and trends on both private and public sector mental health and substance use services, costs, and clients. It addresses the needs of children, military personnel, nursing home residents, and prison inmates.

Using a case study approach, this manual presents resources to better understand and engage the community in responding to children whose caregivers are negatively impacted by mental illness, substance use, or trauma.